Cardiol Therapeutics Inc. Depreciation Expense
Cardiol Therapeutics Inc. (CRDL) reported Depreciation Expense of CAD 101.98 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2026-03-31
| Period end | Depreciation Expense 12 month |
|---|---|
| 2025-12-31 | 101.98K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 162.76K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 163.91K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 135.46K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 135.98K CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 145.09K CAD 20-F · filed 2023-03-29 |